@article{8c691b4ecdff4cf2bbbff3ff00c4bb5f,
title = "Progress towards a neuroimaging biomarker for amyotrophic lateral sclerosis",
author = "Massimo Filippi and Federica Agosta and Julian Grosskreutz and Michael Benatar and Jan Kassubek and Esther Verstraete and Turner, {Martin R.}",
note = "Funding Information: MF serves on scientific advisory boards for Teva Pharmaceutical Industries; has received compensation for consulting services and speaking activities from Biogen Idec, EXCEMED (Excellence in Medical Education), Novartis, and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Teva Pharmaceutical Industries, Novartis, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, Cure PSP, Alzheimer's Drug Discovery Foundation, the Jacques and Gloria Gossweiler Foundation (Switzerland), and ARiSLA (Fondazione Italiana di Ricerca per la SLA). FA has received speaker's honoraria from Biogen Idec and EXCEMED, and receives research supports from the Italian Ministry of Health and AriSLA. EV has received compensation for consulting services as a member of the ALS Imaging Advisory Board for Biogen Idec. MRT has been a paid consultant to the Biogen Neuroimaging Advisory Panel. JG, MB, and JK declare no competing interests.",
year = "2015",
month = aug,
day = "1",
doi = "10.1016/S1474-4422(15)00134-9",
language = "English",
volume = "14",
pages = "786--788",
journal = "The Lancet Neurology",
issn = "1474-4422",
number = "8",
}